Talmadge, James E. Author
Biography not available.
Browse all ART CRITICISM books
Browse all Ashworth books
Browse all FOLKLORE books
Browse all GARDENS books
Browse all GRAPHIC NOVELS books
Browse all Hamilton books
Browse all HISTORY - MEDIEVAL books
Browse all HUMOUR books
Browse all Juvenile Fiction : Biographical - Other books
Browse all Juvenile Fiction : Historical - Other books
Browse all Juvenile Fiction : Legends, Myths, & Fables - Other books
Browse all Juvenile Fiction : People & Places - Other books
Browse all Juvenile Fiction : People & Places - United States - Other books
Browse all Juvenile Fiction : Religious - Other books
Browse all Juvenile Nonfiction : History - Other books
Browse all Juvenile Nonfiction : Mathematics - Advanced books
Browse all Juvenile Nonfiction : People & Places - Other books
Browse all Juvenile Nonfiction : People & Places - United States - Othe books
Browse all KINDRED books
Browse all LITERARY STUDIES books
Browse all LONDON books
Browse all Lozada books
Browse all Medical : Nursing - Mental Health books
Browse all MIND books
Browse all MUSEOLOGY books
Browse all NON-CLASSIFIABLE books
Browse all NONLINEAR SCIENCE books
Browse all Ormonde books
Browse all POPULAR SCIENCE books
Browse all RELIGIOUS STUDIES books
Browse all SPIRIT books
Browse all SPORT books
Browse all TRAVEL WRITING books
Out of Stock
SCREENING FOR BIOLOGICAL RESPO
Hardback · ISBN 9780898387124
Inclusive of GST and other taxes
Arriving at your doorstep in 10-15 days
Our logisitcs team will make sure everyitem is delivered safely
| ISBN | 9780898387124 |
|---|---|
| Subtitle | SCREENING FOR BIOLOGICAL RESPO |
| Publisher | Springer |
| Publication date | April 1985 |
| Language | English |
| MRP | £89.99 GBP |
| Page count | 212 |
| Item weight | 105 g |
The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor responses in patients with refractory lymphoma initiated a massive search for active chemotherapeutic agents. The initial observations stimulated a search for new chemotherapeutic agents which might have increased antitumor activity with less toxicity for normal tissues. To aid in the search for these new chemicals and to attempt to distinguish among the many toxic chemicals which might be candidates for clinical studies, the National Cancer Institute, the pharmaceutical industry, and the cancer research laboratories of most Western nations developed systems for "screening" drugs for antitumor activity. Perhaps the most extensive screening program was established by the National Cancer Institute (1). This screening program has evolved over the last two decades, an evolution which has been repeatedly reviewed (2-5). Various screening programs in use have examined over 500,000 compounds as potential anticancer agents. From these, there are now approximately forty anticancer drugs in clinical use. The utiliy of these compounds and their toxicities have been reviewed on many occasions. It is now apparent that more active and less toxic anticancer drugs are needed. It is also clear that the current screening programs are identifying compounds with similar levels of activity and with continuing moderate to severe toxicity (6).
Log in to write a review for this book.
No reviews yet. Be the first to share your opinion.
Biography not available.
Biography not available.
Biography not available.